Catalyst Wire Dossier Catalyst Wire Dossier

Abametapir Lotion 0.74%

abametapir · Dr. Reddy's Laboratories Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abametapir Lotion 0.74%, covering 2021-05-11 to 2021-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation [Phase 2]

See pricing